The Oncology Grand Rounds series is designed to place original reports published in the
Journal into clinical context. A case presentation is followed by a description of diagnostic …

Because of tremendous advances in HIV care, the survival of many people living with HIV
(PLWH) now approaches that of the general population. This has led to a shift in the types of …

HIV is associated with an excess cancer risk, particularly of lymphoid malignancies. Modern
therapeutics has changed the landscape of HIV disease and typical opportunistic …

This review highlights current interventional clinical trials for HIV-associated malignancies
(HIVAMs), with emphasis on 4 mechanistic areas: immunomodulatory therapies and gene …

The introduction of highly active antiretroviral therapy (ART) has deeply modified the
outcome of HIV patients by improving their overall survival and ameliorating their quality of …

The optimal antiretroviral therapy (ART) regimen for human immunodeficiency virus (HIV)–
infected patients with cancer remains unknown, as clinical trials are lacking and published …

Since the emergence of HIV in the United States in the 1980s, cancer has been a part of the
story. The good news is that antiretroviral therapy has improved survival for those living with …

Cancer has been linked to HIV since the earliest days of the epidemic. The unusually
frequent occurrence of Kaposi sarcoma (KS) among men who have sex with men (MSM) in …

Malignancies represent a major cause of morbidity and mortality in human
immunodeficiency virus (HIV)-infected patients. The introduction of combined antiretroviral …

Implementation of highly active antiretroviral therapy (HAART) has deeply changed the
landscape of HIVassociated malignancies. Some AIDS-defining tumors, namely Primitive …